Proteus mirabilis is an opportunistic pathogen and is responsible for more than 40% of all cases of catheter-associated urinary tract infections (CAUTIs). Healthcare-associated infections have been aggravated by the constant emergence of antibiotic-resistant bacterial strains. Because of this, the use of phages to combat bacterial infections gained renewed interest. In this study, we describe the biological and genomic features of two P. mirabilis phages, named BigMira and MidiMira. These phages belong to the Acadevirus genus (family Autographiviridae). BigMira and MidiMira are highly similar, differing only in four missense mutations in their phage tail fiber. These mutations are sufficient to impact the phages’ depolymerase activity. Subsequently, the comparative genomic analysis of ten clinical P. mirabilis strains revealed differences in their antibiotic resistance profiles and lipopolysaccharide locus, with the latter potentially explaining the host range data of the phages. The massive presence of antimicrobial resistance genes, especially in the phages’ isolation strain P. mirabilis MCS, highlights the challenges in treating infections caused by multidrug-resistant bacteria. The findings reinforce BigMira and MidiMira phages as candidates for phage therapy purposes.
Bacteriophages offer a targeted approach to industrial biocontrol, with the potential to control undesirable bacteria while limiting direct effects on nonsusceptible microorganisms. However, their compatibility with microbial functions essential to saline produced-water treatment remains poorly understood. This study evaluated produced-water treatment microcosms after a single application of a four-phage cocktail at 107 PFU mL−1. Sludge that acclimated to 55 or 125 g L−1 NaCl was monitored for ammonia removal, infective phage persistence, cell membrane integrity, and prokaryotic community composition. Control microcosms maintained ammonia removal above 94%, whereas treated systems showed a transient reduction after cocktail application. Ammonia removal recovered to above 90% by day 16 at 55 g L−1 NaCl and by day 55 at 125 g L−1 NaCl, indicating a more persistent response at higher salinity. Infective phage titers declined by day 6 and were undetectable from day 8 onward, with no evidence of detectable phage amplification. Fluorescence microscopy indicated greater membrane permeabilization in phage-treated microcosms at higher salinity. The microbial community remained dominated by Proteobacteria, particularly Halomonas. Overall, phage cocktail application coincided with a temporary and reversible decline in ammonia removal, particularly at higher salinity, emphasizing the need to evaluate its compatibility with essential biological treatment functions before practical implementation.